Vir Biotechnology, Inc.
VIR
$9.40
$0.111.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 272.89% | -11.91% | -83.90% | -81.24% | -79.08% |
| Total Other Revenue | -19.40% | 124.34% | -- | -- | -- |
| Total Revenue | 213.96% | -7.61% | -78.55% | -75.91% | -73.79% |
| Cost of Revenue | -14.15% | -9.33% | -7.08% | 12.78% | 0.55% |
| Gross Profit | 23.66% | 9.63% | -6.09% | -31.37% | -14.05% |
| SG&A Expenses | -14.24% | -22.65% | -28.75% | -33.66% | -34.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.16% | -11.88% | -11.61% | 1.34% | -7.98% |
| Operating Income | 22.01% | 12.46% | 2.21% | -12.95% | -0.71% |
| Income Before Tax | 23.61% | 16.31% | 7.38% | -11.72% | -5.28% |
| Income Tax Expenses | 126.41% | 118.95% | 104.59% | 103.00% | 86.71% |
| Earnings from Continuing Operations | 23.36% | 16.09% | 6.32% | -13.91% | -7.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.36% | 16.09% | 6.32% | -13.91% | -7.08% |
| EBIT | 22.01% | 12.46% | 2.21% | -12.95% | -0.71% |
| EBITDA | 22.27% | 12.26% | 1.46% | -14.64% | -1.66% |
| EPS Basic | 25.74% | 17.32% | 7.74% | -12.10% | -5.24% |
| Normalized Basic EPS | 22.14% | 9.37% | -1.89% | -19.63% | -3.80% |
| EPS Diluted | 25.74% | 17.32% | 7.84% | -11.97% | -5.12% |
| Normalized Diluted EPS | 22.14% | 9.37% | -1.89% | -19.63% | -3.80% |
| Average Basic Shares Outstanding | 3.07% | 1.67% | 1.64% | 1.66% | 1.66% |
| Average Diluted Shares Outstanding | 3.07% | 1.67% | 1.64% | 1.66% | 1.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |